A company called eGenesis is working on solving the organ donor shortage using new genome engineering techniques. The company has made progress in developing a kidney transplant procedure, including receiving clearance for a related treatment, and has raised significant funding to advance its lead program. It appears that eGenesis's approach involves the use of gene-edited pigs, although the specifics and outcomes of this work are not yet fully clear.